[The ovarian hyperstimulation syndrome. Institutional experience].
Thirty patients with OHS were analyzed; all of them had to be hospitalized. There was no difference as to sterility time and syndrome appearance. The use of menotropines caused more frequently the syndrome. There was multiple pregnancy in 33%. Abortion incidence was 16%. As the etiology is unknown there is not an adequate treatment, and care is for maintenance. Prevention is the best option.
Serviere Zaragoza
C
C
Unidad de Reproducción Asistida, Instituto Nacional de Perinatología, SS, México, D.F.
Camarero García
A
A
Carranza Lira
S
S
Kably Ambe
A
A
D000328:Adult; D002996:Clomiphene / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D008596:Menotropins / Q000627:therapeutic use; D008800:Mexico; D016471:Ovarian Hyperstimulation Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D010062:Ovulation Induction; D011247:Pregnancy; D012189:Retrospective Studies
D002996:Clomiphene; D008596:Menotropins; D005640:Follicle Stimulating Hormone
Síndrome de hiperestimulación ovárica. Experiencia institucional.